Stroke Prevention by ORal Thrombin Inhibition V "SPORTIF V"

Completed

Phase N/A Results

References

Source for Trial Information

  • Press reports 4/03. AstraZeneca. American Society of Hematology 2002 Meeting Abstract. JAMA. 2005 Feb 9;293(6):690-8.